Less than 1% of patients were on Eli Lilly's tirzepatide, which didn't get Food and Drug Administration approval as a diabetes drug, Mounjaro, until 2022
Chronic functional bowel syndrome worsens gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia
GLP-1 medications help the body manage blood sugar more efficiently, which can lead to steadier energy, fewer glucose spikes, and reduced inflammatory stress on the body.These shifts support sustainable, long-term health rather than temporary results
Product Citation: PubMed 35664796 SKU: N/A Category: SMAD2 Additional information Additional information Data show the superior performance of the new Phospho-SMAD2 Assay compared to the previous version of the assay
Thus, they align therapeutic development with global sustainability goals [10, 11]